etalpha mjúkt hylki 1 míkróg
cheplapharm arzneimittel gmbh - alfacalcidolum inn - mjúkt hylki - 1 míkróg
etalpha mjúkt hylki 0,25 míkróg
cheplapharm arzneimittel gmbh - alfacalcidolum inn - mjúkt hylki - 0,25 míkróg
duta tamsaxiro hart hylki 0,5/0,4 mg
medical valley invest ab - dutasteridum inn; tamsulosinum hýdróklóríð - hart hylki - 0,5/0,4 mg
zenalpha
vetcare oy - medetomidine hydrochloride, vatinoxan hydrochloride - psycholeptics, svefnlyf og róandi lyf - hundar - to provide restraint, sedation and analgesia during conduct of non-invasive, non-painful or mildly painful procedures and examinations intended to last no more than 30 minutes.
alpha ject 3000 stungulyf, fleyti
pharmaq as* - aeromonas salmonicida subs. salmonicida al 2017; vibrio anguillarum serotype o1 al 112; vibrio anguillarum serotype 02 al 104 - stungulyf, fleyti
alpha ject 5-3 stungulyf, fleyti
pharmaq as* - aeromonas salmonicida subsp. salmonicida; vibrio salmonicida; listonella anguillarum serotype o1; listonella anguillarum serotype o2a; moritella viscosa - stungulyf, fleyti
alpha ject micro 5 stungulyf, fleyti ein.
pharmaq as* - aeromonas salmonicida subs. salmonicida al 2017; vibrio anguillarum serotype o1 al 112; vibrio anguillarum serotype 02 al 104; moritella viscosa; vibrio salmonicida - stungulyf, fleyti - ein.
duodart hart hylki 0,5/0,4 mg
glaxosmithkline pharma a/s - dutasteridum inn; tamsulosinum hýdróklóríð - hart hylki - 0,5/0,4 mg
dutasteride/tamsulosin teva (dutasteride/tamsulosinehydrochloride teva) hart hylki 0,5 mg/0,4 mg
teva b.v.* - dutasteridum inn; tamsulosinum hýdróklóríð - hart hylki - 0,5 mg/0,4 mg
suiseng diff/a
laboratorios hipra, s.a. - clostridioides difficile toxoid a, clostridioides difficile toxoid b, clostridium perfringens, type a, alpha toxoid - immunologicals for suidae, inactivated bacterial vaccines for pigs, clostridium - svín - for the passive immunisation of neonatal piglets by means of the active immunisation of breeding sows and gilts:- to prevent mortality and reduce clinical signs and macroscopic lesions caused by clostridioides difficile toxins a and b. - to reduce clinical signs and macroscopic lesions caused by clostridium perfringens type a, alpha toxin.